Matrix metalloproteinase-2 protein in lung periphery is related to COPD progression

Chest

Volumn 132, Issue 6, 2007, Pages 1733-1740

  Baraldo, Simonetta ^a   Bazzan, Erica ^a   Zanin, Maria Elena ^a   Turato, Graziella ^a   Garbisa, Spiridione ^a   Maestrelli, Piero ^a   Papi, Alberto ^b   Miniati, Massimo ^c   Fabbri, Leonardo M ^d   Zuin, Renzo ^a   Saetta, Marina ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY OF FERRARA   (Italy)

^c Institute of Nuclear Studies   (Italy)

^d UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Airflow limitation; Cigarette smoking; Emphysema; Extracellular matrix; Inflammation

Indexed keywords

GELATINASE A;

ADULT; AGED; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; EMPHYSEMA; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ALVEOLUS MACROPHAGE; LUNG ALVEOLUS WALL; LUNG BLOOD VESSEL; LUNG EMPHYSEMA; LUNG FUNCTION TEST; MALE; OXYGEN SATURATION; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESIDUAL VOLUME; SMOKING; STATISTICAL SIGNIFICANCE;

EID: 37149038761     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.06-2819     Document Type: Article

References (50)

1. Celli BR, MacNee W, ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004; 23:932-946
2. MacNee W. Pathogenesis of chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2:258-266
3. Hogg JC, Chu F, Utokaparch S, et al. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 2004; 350:2645-2653
4. Saetta M, Turato G, Maestrelli P, et al. Cellular and structural bases of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 163:1304-1309
5. van de Lest CHA, Versteeg EMM, Veerkamp JH, et al. Digestion of proteoglycans in porcine pancreatic elastase-induced emphysema in rats. Eur Respir J 1995; 8:238-245
6. Elkington PTF, Friedland JS. Matrix metalloproteinases in destructive pulmonary pathology. Thorax 2006; 61:259-266
7. Gueders MM, Foidart JM, Noel A, et al. Matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs in the respiratory tract: potential implications in asthma and other lung diseases. Eur J Pharmacol 2006; 533:133-144
8. Shapiro SD. The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160:S29-S32
9. Hautamaki RD, Kobayashi DK, Senior RM. Requirement for macrophage elastase for cigarette smoke-induced emphysema in mice. Science 1997; 277:2002-2004
10. Morris DG, Huang X, Kaminsky N, et al. Loss of integrin alpha(v)beta6-mediated TGFβ activation causes MMP-12 dependent emphysema. Nature 2003; 22:169-173
11. Imai K, Dalal SS, Chen E, et al. Human collagenase (matrix metalloproteinase-1) expression in the lung of patients with emphysema. Am J Respir Crit Care Med 2001; 163:786-791
12. Finlay GA, O' Driscoll LR, Russell KJ. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med 1997; 156:240-247
13. Russell RE, Culpitt SV, Dematos C, et al. Release and activity of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by alveolar macrophages from patients with chronic obstructive pulmonary disease. Am J Respir Cell Mol Biol 2002; 26:602-609
14. Segura-Valdez L, Pardo A, Gaxiola M, et al. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 2000; 117:684-694
15. Ohnishi K, Takagi M, Kurokawa Y, et al. Matrix metalloproteinase-mediated extracellular matrix protein degradation in human pulmonary emphysema. Lab Invest 1998; 78:1077-1087
16. Cataldo D, Munaut C, Noël A, et al. MMP-2- and MMP-9-linked gelatinolytic activity in the sputum from patients with asthma and chronic obstructive pulmonary disease. Int Arch Allergy Immunol 2000; 123:259-267
17. Vignola AM, Riccobono L, Mirabella A, et al. Sputum metalloproteinase-9/ tissue inhibitor of metalloproteinase-1 ratio correlates with airflow obstruction in asthma and chronic bronchitis. Am J Respir Crit Care Med 1998; 158:1945-1950
18. Culpitt S, Rogers D, Traves S, et al. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma. Respir Med 2005; 99:703-710
19. Vignola AM, Paganin F, Capieu L, et al. Airway remodelling assessed by sputum and high-resolution computed tomography in asthma and COPD. Eur Respir J 2004; 24:910-917
20. Vernooy JH, Lindeman JH, Jacobs JA, et al. Increased activity of matrix metalloproteinase-8 and matrix metalloproteinase-9 in induced sputum from patients with COPD. Chest 2004; 126:1802-1810
21. Betsuyaku T, Nishimura M, Takeyabu K, et al. Neutrophil granule proteins in bronchoalveolar lavage fluid from subjects with subclinical emphysema. Am J Respir Crit Care Med 1999; 159:1985-1991
22. Masumoto K, de Rooij D, Suita S, et al. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases during normal human pulmonary development. Histopathology 2005; 47:410-419
23. Johnson S, Knox A. Autocrine production of matrix metalloproteinase-2 is required for human airway smooth muscle proliferation. Am J Physiol 1999; 277:L1109-L1117
24. Madri JA, Graesser D, Haas T. The roles of adhesion molecules and proteinases in lymphocyte transendothelial migration. Biochem Cell Biol 1996; 74:749-757
25. Chung A, Gao Q, Kao WJ. Macrophage matrix metalloproteinase-2/-9 gene and protein expression following adhesion to ECM-derived multifunctional matrices via integrin complexation. Biomaterials 2007; 28:285-298
26. McQuibban GA, Gong JH, Tam EM, et al. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 2000; 289:1202-1206
27. Parks WC, Wilson CL, Lopez-Boado YS, et al. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat Rev 2004; 4:617-629
28. Abraham M, Shapiro S, Karni A, et al. Gelatinases (MMP-2 and MMP-9) are preferentially expressed by Th1 vs Th2 cells. J Neuroimmunol 2005; 163:157-164
29. Saetta M, Mariani M, Panina-Bordignon P, et al. Increased expression of the chemokine receptor CXCR3 and its ligand CXCL10 in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2002; 165:1404-1409
30. Grumelli S, Corry D, Song L, et al. An immune basis for lung parenchymal destruction in cronic obstructive pulmonary disease and emphysema. PLoS Med 2004; 1:e8
31. Saetta M, Di Stefano A, Maestrelli P, et al. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med 1994; 150:1646-1652
32. Industrial Health and Medicine. Aide-memoire of sphirographic practice for examining ventilatory function. 2nd ed. Luxembourg, Belgium: Communitè Europeenne du Carbon et de l'Acier, 1971
33. Miniati M, Filippi E, Falaschi F, et al. Radiologic evaluation of emphysema in patients with chronic obstructive pulmonary disease: chest radiography versus high resolution computed tomography. Am J Respir Crit Care Med 1995; 151:1359-1367
34. Selman M, Montano M, Ramos C. Tobacco smoke-induced lung emphysema in guinea pigs is associated with increased interstitial collagenase. Am J Physiol 1996; 271:L734-L743
35. Molet S, Belleguic C, Lena H, et al. Increase in macrophage elastase (MMP-12) in lungs from patients with chronic obstructive pulmonary disease. Inflamm Res 2005; 54:31-36
36. Welgus HG, Campbell EJ, Cury JD, et al. Neutral metalloproteinases produced by human mononuclear phagocytes. J Clin Invest 1990; 86:1496-1502
37. Wilhelm SM, Collier IE, Marmer BL, et al. SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. J Biol Chem 1989; 264:17213-17221
38. Retamales I, Elliott WM, Meshi B, et al. Amplification of inflammation in emphysema and its association with latent adenoviral infection. Am J Respir Crit Care Med 2001; 164:469-473
39. Turato G, Zuin R, Miniati M, et al. Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema. Am J Respir Crit Care Med 2002; 166:105-110
40. Augusti A, Mac Nee W, Donaldson K, et al. Hypothesis: does COPD have an autoimmune component? Thorax 2003; 8:832-884
41. Cosio MG, Majo J, Cosio MG. Inflammation of the airways and lung parenchyma in COPD: role of T cells. Chest 2002; 121:160S-165S
42. Lee SH, Goswami S, Grudo A, et al. Antielastin autoimmunity in tobacco smoking-induced emphysema. Nat Med 2007; 13:567-569
43. Saetta M, Baraldo S, Corbino L, et al. CD8+ve cells in the lungs of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1999; 160:711-717
44. Majo J, Ghezzo H, Cosio M. Lymphocyte population and apoptosis in the lungs of smokers and their relation with emphysema. Eur Respir J 2001; 17:946-953
45. Di Stefano A, Capelli A, Lusuardi M, et al. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am J Respir Crit Care Med 1998; 158:1277-1285
46. Wassua-Kintu S, Gan WQ, Man SFP, et al. Relationship between reduced forced expiratory volume in one second and the risk of lung cancer: a systematic review and meta-analysis. Thorax 2005; 60:570-575
47. Papi A, Casoni GL, Guzzinati I, et al. COPD increases the risk of squamous histological subtype in smokers who develop non small cell lung carcinoma. Thorax 2004; 59:679-681
48. Choi J, Choi K, Benveniste EN, et al. Bcl-2 promotes invasion and lung metastasis by inducing matrix metalloproteinase-2. Cancer Res 2005; 65:5554-5560
49. Hoikkala S, Paakko P, Soini Y, et al. Tissue MMP-2/TIMP-2 complex are better prognostic factors that serum MMP-2, MMP-9 or TIMP-1 in stage I-III lung carcinoma. Cancer Lett 2006; 236:125-132
50. Fujimoto N, Mouri N, Iwata K, et al. A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 2 (72-kDa gelatinase/type IV collagenase) using monoclonal antibodies. Clin Chim Acta 1993; 221:91-103